Hellenic Dynamics (LSE:HELD) EV-to-EBIT: -1.46 (As of Aug. 16, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Hellenic Dynamics EV-to-EBIT?

Hellenic Dynamics LSE:HELD EV-to-EBIT is -1.46 as of Aug. 16, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Hellenic Dynamics's Enterprise Value is £1.40 Mil. Hellenic Dynamics's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.96 Mil. Therefore, Hellenic Dynamics's EV-to-EBIT for today is -1.46.

The historical rank and industry rank for Hellenic Dynamics's EV-to-EBIT or its related term are showing as below:

LSE:HELD's EV-to-EBIT is not ranked *
in the Drug Manufacturers industry.
Industry Median: 15.99
* Ranked among companies with meaningful EV-to-EBIT only.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Hellenic Dynamics's Enterprise Value for the quarter that ended in Sep. 2023 was £10.16 Mil. Hellenic Dynamics's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.96 Mil. Hellenic Dynamics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 was -9.42%.


Hellenic Dynamics  (LSE:HELD) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Hellenic Dynamics's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Sep. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Sep. 2023 ) =EBIT / Enterprise Value (Q: Sep. 2023 )
=-0.957/10.162
=-9.42 %

Hellenic Dynamics's Enterprise Value for the quarter that ended in Sep. 2023 was £10.16 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hellenic Dynamics's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hellenic Dynamics EV-to-EBIT Related Terms


Hellenic Dynamics EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Hellenic Dynamics's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hellenic Dynamics EV-to-EBIT Chart

Hellenic Dynamics Annual Data
Trend Dec19 Dec20
EV-to-EBIT
0.00 0.00

Hellenic Dynamics Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Sep23
EV-to-EBIT Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

LSE:HELD vs ZTS, NBIX, VTRS: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Hellenic Dynamics's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hellenic Dynamics EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Hellenic Dynamics's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hellenic Dynamics's EV-to-EBIT falls into.



Hellenic Dynamics EV-to-EBIT Calculation

Hellenic Dynamics's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=1.396/-0.957
=-1.46

Hellenic Dynamics's current Enterprise Value is £1.40 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Hellenic Dynamics's EBIT for the trailing twelve months (TTM) ended in Sep. 2023 was £-0.96 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -1.46 mean?
Hellenic Dynamics (LSE:HELD) has a EV-to-EBIT of -1.46 as of Aug. 16, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Hellenic Dynamics and its competitors.
Is Hellenic Dynamics' EV-to-EBIT too high?
Hellenic Dynamics' current EV-to-EBIT is -1.46.
How does Hellenic Dynamics' EV-to-EBIT compare to ZTS and NBIX?
Hellenic Dynamics' EV-to-EBIT of -1.46 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBIT is 15.99. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.99, based on 684 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Hellenic Dynamics and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.99 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hellenic Dynamics's current EV-to-EBIT is -1.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hellenic Dynamics stock overvalued right now?
Hellenic Dynamics (LSE:HELD) has a current EV-to-EBIT of -1.46. The current EV-to-EBIT is -1.46. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Hellenic Dynamics (LSE:HELD), the current EV-to-EBIT is -1.46 as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hellenic Dynamics Business Description

Address 3 Soothouse Spring, Suite 18 Stanta Business Centre, St. Albans, Hertfordshire, GBR, SW1A 1RN
Hellenic Dynamics PLC is engaged in the cultivation, and supply of tetrahydrocannabinol (THC) dominant strains of medical cannabis flowers, destined for the growing medical cannabis markets across Europe.